Robert A. Roschmann

Statistics

Publications

Citations

347

H-Index

Active since

2010

Affiliations

Roche (United Kingdom)(Current)

Robert A. Roschmann is an author at Roche (United Kingdom) specializing in rituximab-based therapy, immunotherapy, and refractory rheumatoid arthritis.

Publications per year

2010–2010

Publications

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

P. Emery, Atul Deodhar, William F. C. Rigby et al. · Annals of the Rheumatic Diseases · 2010 · 347 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–1 of 1